-
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
-
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
Forward Look
Speeding Up Multiple Myeloma Drug DevelopmentHematologist-oncologist C. Ola Landgren explains how measuring minimal residual disease could be useful in multiple myeloma clinical trials.
by Anna Azvolinsky
-
From the Editor-in-Chief
A New Treatment for Some Brain TumorsA recently approved therapy targets abnormal enzymes produced by gene defects.
by William G. Nelson, MD, PhD
-
Forward Look
Stem Cell Transplant Rates Decrease for LymphomaMore patients are receiving CAR T-cell therapy for large B-cell lymphoma.
by Leah Lawrence
-
Forward Look
Mobilizing an Immune Response in Metastatic Prostate CancerA new approach that uses a probe to freeze tumor cells followed by an infusion of immune-boosting drugs shows promising results in an early clinical trial.
-
Forward Look
Ushering in a New Standard of CareTargeted therapy extends progression-free survival in people with stage III EGFR-mutated lung cancer.
by Darcy Lewis
-
Making Their MarkWith targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Survivor Profile
A Cause for ConcernMargie Wilson is helping Black women understand their risk for endometrial cancer and teaching them not to ignore the warning signs.
by Taayoo Murray
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
